Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:2862-2866
Published online before print October 28, 2004, doi: 10.1161/01.STR.0000147714.19871.45
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/12/2862    most recent
01.STR.0000147714.19871.45v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sztriha, L. K.
Right arrow Articles by Vécsei, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sztriha, L. K.
Right arrow Articles by Vécsei, L.
Related Collections
Right arrow Angioplasty and Stenting
Right arrow Carotid Stenosis

(Stroke. 2004;35:2862.)
© 2004 American Heart Association, Inc.


Original Contributions

Favorable Early Outcome of Carotid Artery Stenting Without Protection Devices

László K. Sztriha, MD; Erika Vörös, MD, PhD; Katalin Sas, MD; Réka Szentgyörgyi, MD, PhD; Anna Pócsik, MD; Pál Barzó, MD, PhD; Péter Szikra, BSc; Attila Makai, MD; Alex Szólics; Péter Elek, MD; László Rudas, MD, PhD, DSc László Vécsei, MD, PhD, DSc

From the Departments of Neurology (L.K.S., K.S., L.V.), Radiology (E.V., R.S., A.P., P.S., A.S.), Neurosurgery (P.B., P.E.), and the Medical Intensive Care Unit (A.M., L.R.), Cardiology Center, Albert Szent-Györgyi Medical and Pharmaceutical Center, University of Szeged; and the Neurology Research Group of the Hungarian Academy of Sciences and University of Szeged (L.V.), Szeged, Hungary.

Correspondence to Dr Laszlo K. Sztriha, Department of Neurology, Albert Szent-Györgyi Medical and Pharmaceutical Center, University of Szeged, Semmelweis u. 6, H-6725 Szeged, Hungary. E-mail sztriha{at}nepsy.szote.u-szeged.hu

Background and Purpose— Protection devices are increasingly used in carotid artery stenting. However, no randomized trial has been conducted to evaluate the efficacy of such devices, and arguments have also been formulated against their routine use. We set out to investigate the complication rates associated with carotid artery stenting performed without protection devices. Applicability of covered stents in the carotid system was also evaluated.

Methods— Between January 2001 and July 2003, 245 consecutive patients (260 hemispheres) underwent carotid artery stenting. No protection devices were applied. Covered stents were implanted in 31 (12.1%) cases. The incidence of complications during the intervention and the subsequent 30-day follow-up period was recorded.

Results— The technical success rate was 98.8%. One postprocedural nonneurological death (0.4%) occurred. Neurological complications (inclusive of transient ischemic attacks) were observed in 14 cases (5.4%). The rate of major complications (death, major stroke, and myocardial infarction) was 1.6% among the symptomatic and 1.5% among the asymptomatic cases. The rate of minor strokes was 3.2% in the symptomatic and 1.5% in the asymptomatic group. Of the neurological complications, 64.3% occurred postprocedurally. No ipsilateral neurological complications were detected in the subgroup treated with covered stents.

Conclusions— Carotid artery stenting without protection devices appears to be safe. Most of the neurological complications could not have been prevented with protection devices, because they occurred after the intervention. The application of covered stents may reduce the rate of embolization-related complications in the periprocedural period.


Key Words: carotid arteries • embolism • protective devices • stents




This article has been cited by other articles:


Home page
StrokeHome page
M. Schillinger, M. Gschwendtner, B. Reimers, J. Trenkler, L. Stockx, J. Mair, S. Macdonald, F. Karnel, K. Huber, and E. Minar
Does Carotid Stent Cell Design Matter?
Stroke, March 1, 2008; 39(3): 905 - 909.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
E. Akgul, E.H. Aksungur, K. Korur, K. Aikimbaev, and H. Yaliniz
A Rare Complication of Carotid Artery Stenting: Displacement of Marker Ring Causing Locking of Stent and Incomplete Stent Expansion
AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1403 - 1404.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Hofmann, A. Niessner, A. Kypta, C. Steinwender, J. Kammler, K. Kerschner, M. Grund, F. Leisch, and K. Huber
Risk Score for Peri-Interventional Complications of Carotid Artery Stenting
Stroke, October 1, 2006; 37(10): 2557 - 2561.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
R. du Mesnil de Rochemont, S. Schneider, B. Yan, A. Lehr, M. Sitzer, and J. Berkefeld
Diffusion-Weighted MR Imaging Lesions after Filter-Protected Stenting of High-Grade Symptomatic Carotid Artery Stenoses
AJNR Am. J. Neuroradiol., June 1, 2006; 27(6): 1321 - 1325.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Orlandi, S. Gallerini, M. Cosottini, L. Murri, L. K. Sztriha, E. Voros, P. Szikra, and L. Vecsei
Postprocedural Emboli in Carotid Artery Stenting: Where Do They Come From? * Response:
Stroke, May 1, 2005; 36(5): 928 - 929.
[Full Text] [PDF]